drugset / Trial / NCT06348290

Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects

NCT06348290

Phase 1 Unknown 72 enrolled Jemincare
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is an open-label, non-randomized, clinical study to evaluate the drug interaction between itraconazole, rifampin or Cocktail and JMKX001899 in healthy subjects. A total of three cohorts of 72 healthy subjects were planned to be enrolled in each cohort.

Timeline

Start
2024-04-01
Primary completion
2024-05-31
Completion
2024-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown Oral
Subject Digoxin Other / unclassified Oral
Subject Itraconazole Small molecule Oral
Subject JMKX001899 Unknown Oral
Subject Midazolam Small molecule Oral
Subject Rifampin Small molecule Oral
Subject Rosuvastatin Small molecule Oral

Indications